Connection
Peter Crooks to Treatment Outcome
This is a "connection" page, showing publications Peter Crooks has written about Treatment Outcome.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.133 |
|
|
|
-
Crooks PA, Bardo MT, Dwoskin LP. Nicotinic receptor antagonists as treatments for nicotine abuse. Adv Pharmacol. 2014; 69:513-51.
Score: 0.055
-
Crooks P. International care models for chronic kidney disease: methods and economics--United States. Blood Purif. 2004; 22(1):13-20.
Score: 0.027
-
Maggio SE, Saunders MA, Nixon K, Prendergast MA, Zheng G, Crooks PA, Dwoskin LP, Bell RL, Bardo MT. An improved model of ethanol and nicotine co-use in female P rats: Effects of naltrexone, varenicline, and the selective nicotinic a6?2* antagonist r-bPiDI. Drug Alcohol Depend. 2018 12 01; 193:154-161.
Score: 0.019
-
Lee NR, Zheng G, Crooks PA, Bardo MT, Dwoskin LP. New Scaffold for Lead Compounds to Treat Methamphetamine Use Disorders. AAPS J. 2018 02 09; 20(2):29.
Score: 0.018
-
Nickell JR, Siripurapu KB, Vartak A, Crooks PA, Dwoskin LP. The vesicular monoamine transporter-2: an important pharmacological target for the discovery of novel therapeutics to treat methamphetamine abuse. Adv Pharmacol. 2014; 69:71-106.
Score: 0.014